CartaBio Inc
CartaBio, Inc. develops biotechnology solutions for cellular analysis and drug discovery. The Company utilizes AI-driven single-cell technology and creates immune-modulating therapeutics, collaborating with research institutions and biobanks. CartaBio Inc serves pharmaceutical companies and research institutions in Asia Pacific, Europe, and the United States.